Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 SEK)

NET PROFIT (x1000 SEK)

EMPLOYEES

Share

Calliditas Therapeutics AB

Closing information (x1000 SEK)

Closing information 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Turnover 1,206,888 Less Arrow 802,879 Less Arrow 229,347
Financial expenses 114,349 Less Arrow 37,669 Less Arrow 9,253
Earnings before taxes -457,017 More Arrow -409,417 Less Arrow -513,373
EBITDA -356,461 Less Arrow -409,030 Less Arrow -524,456
Total assets 1,859,245 More Arrow 1,952,973 Less Arrow 1,459,910
Current assets 1,275,152 More Arrow 1,412,204 Less Arrow 1,012,772
Current liabilities 407,144 Less Arrow 325,230 Less Arrow 135,446
Equity capital 334,806 More Arrow 766,263 More Arrow 1,008,281
- share capital 2,383 Equal arrow 2,383 Less Arrow 2,094
Employees (average) 181 Less Arrow 86 Less Arrow 56

Financial ratios

Fiscal year 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Solvency 18.0% More Arrow 39.2% More Arrow 69.1%
Turnover per employee 6,668 More Arrow 9,336 Less Arrow 4,095
Profit as a percentage of turnover -37.9% Less Arrow -51.0% Less Arrow -223.8%
Return on assets (ROA) -18.4% Less Arrow -19.0% Less Arrow -34.5%
Current ratio 313.2% More Arrow 434.2% More Arrow 747.7%
Return on equity (ROE) -136.5% More Arrow -53.4% More Arrow -50.9%
Change turnover 404,009 More Arrow 573,532 Less Arrow 228,473
Change turnover % 50% More Arrow 250% More Arrow 26141%
Chg. No. of employees 95 Less Arrow 30 More Arrow 33
Chg. No. of employees % 110% Less Arrow 54% More Arrow 143%

Total value of public sale

Fiscal year 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.